Boehringer Ingelheim is preparing for multiple drug launches in the second half of 2025, following strong first-half financial results that saw the company report a 6.3% rise in group net sales to €14 ...

The Global Findex Database is the world's only demand-side survey on financial inclusion and a leading source of data on how adults around the world access and use financial services. Since its launch ...